Columbia researchers found that exposure to famine early in gestation—but not in the first years of life or late gestation—increased the risk of developing type 2 diabetes decades later.
A new BRAIN Initiative atlas showcases the diverse cell populations within the human hypothalamus, paving the way to discovering novel cellular targets for obesity and metabolic disease
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
A new study from Columbia pediatricians found that new mothers are more receptive to educational materials that contain facts, not criticism, about sugary drinks.
Fat cells emit nanoparticles loaded with lipids that may keep fat tissue healthy and play a role in preventing diabetes, according to a new study published in Science.
Columbia scientists are using CRISPR to create stem cells that could ultimately alleviate diabetes in rare neonatal cases and may lead to a cell therapy for more common forms of the disease.
Increasingly, transformative therapies are being launched via startups emerging from university research labs, including those at Columbia’s Vagelos College of Physicians and Surgeons.
Researchers have identified thousands of molecules—produced by “junk” DNA—that are found only in human fat cells and play an important role in how we store and use fat.
Pediatric gastroenterologist Jennifer Woo Baidal explains that obesity may increase the risk of a serious liver disease at a much younger age than once thought.
High plasma triglycerides have been linked to heart disease; studies in mice suggest inhibiting gamma secretase in the liver could lower plasma triglyceride levels and have parallel benefits for diabetes.